Exercise Program for Patients With Cervical Dystonia Who Are Treated With Botulinum Toxin Type A
Launched by PROF. DR. ŞEHIM KUTLAY · Aug 14, 2022
Trial Information
Current as of July 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a personalized exercise program for patients with cervical dystonia who are receiving botulinum toxin type A injections. Cervical dystonia is a condition that causes involuntary movements and abnormal postures of the neck, which can lead to pain and difficulties in daily activities. The trial aims to see if adding specific exercises—like stretching and strengthening—can improve patients' quality of life and reduce their symptoms compared to a control group that will only do basic breathing and coordination exercises.
To participate, individuals must be over 18 years old, have a confirmed diagnosis of cervical dystonia, and be receiving treatment at Ankara University. They should also be able to access exercise videos on a computer or mobile device. However, anyone with serious health issues that might prevent them from exercising, or with certain mental health conditions, cannot join the study. Participants can expect to engage in a tailored exercise program that may help manage their symptoms better alongside their regular treatment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Be over 18 years old
- • Completion of Informed Signed Consent Form
- • Diagnosis of cervical dystonia by neurology
- • Botulinum toxin injection for cervical dystonia in Ankara University Faculty of Medicine Neurology Department Movement Disorders Outpatient Clinic
- • To have the necessary infrastructure to watch the prepared exercise videos on computers, phones, tablets.
- Exclusion Criteria:
- • Cardiovascular, systemic or musculoskeletal problems that prevent participation in the exercise program
- • Presence of dementia/cognitive disorder or symptomatic psychiatric disease, which was previously diagnosed or detected during the anamnesis process, preventing participation in the program
- • Failure to approve the Informed Signed Consent Form
About Prof. Dr. şehim Kutlay
Prof. Dr. Şehim Kutlay is a distinguished clinical trial sponsor renowned for his extensive expertise in medical research and commitment to advancing healthcare. With a robust background in clinical methodologies and a focus on innovative treatment approaches, Dr. Kutlay leads multidisciplinary teams in the design and execution of trials that adhere to the highest ethical and regulatory standards. His work emphasizes patient-centered outcomes and aims to bridge the gap between scientific discovery and practical application, ultimately contributing to the development of effective therapeutic strategies in various medical fields.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Ankara, Altındağ, Turkey
Patients applied
Trial Officials
Sehim Sehim
Study Director
sehim.kutlay@gmail.com
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials